May Orfali - CHIEF MEDICAL OFFICER at Sigilon Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
SGTX
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by May Orfali since 12/22/2023

Holdings reported by May Orfali for Sigilon Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 10K $7.5K $0.75 Feb 18, 2022 Direct Common Stock

Transactions reported by May Orfali for Sigilon Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.